HomeCompareOTPMF vs PFE

OTPMF vs PFE: Dividend Comparison 2026

OTPMF yields 45.25% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OTPMF wins by $257.8K in total portfolio value
10 years
OTPMF
OTPMF
● Live price
45.25%
Share price
$4.42
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$307.4K
Annual income
$57,479.41
Full OTPMF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — OTPMF vs PFE

📍 OTPMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOTPMFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OTPMF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OTPMF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OTPMF
Annual income on $10K today (after 15% tax)
$3,846.15/yr
After 10yr DRIP, annual income (after tax)
$48,857.50/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, OTPMF beats the other by $26,537.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OTPMF + PFE for your $10,000?

OTPMF: 50%PFE: 50%
100% PFE50/50100% OTPMF
Portfolio after 10yr
$178.5K
Annual income
$41,869.06/yr
Blended yield
23.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

OTPMF
No analyst data
Altman Z
8.7
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OTPMF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOTPMFPFE
Forward yield45.25%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$307.4K$49.6K
Annual income after 10y$57,479.41$26,258.71
Total dividends collected$239.3K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OTPMF vs PFE ($10,000, DRIP)

YearOTPMF PortfolioOTPMF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$15,225$4,524.89$9,153$693.39+$6.1KOTPMF
2$22,729$6,438.40$8,593$849.25+$14.1KOTPMF
3$33,303$8,982.99$8,336$1,066.78+$25.0KOTPMF
4$47,935$12,301.00$8,437$1,384.80+$39.5KOTPMF
5$67,838$16,547.33$9,013$1,875.40+$58.8KOTPMF
6$94,473$21,885.79$10,306$2,680.72+$84.2KOTPMF
7$129,570$28,484.63$12,820$4,101.38+$116.8KOTPMF
8$175,151$36,511.23$17,673$6,826.70+$157.5KOTPMF
9$233,539$46,126.56$27,543$12,591.86+$206.0KOTPMF
10$307,366$57,479.41$49,560$26,258.71+$257.8KOTPMF

OTPMF vs PFE: Complete Analysis 2026

OTPMFStock

OPTiM Corporation provides various internet-based services in Japan. It offers AI services, including OPTiM artificial intelligence (AI) Camera, an image analysis service and OPTiM Physical Security; Internet of Things (IoT) services, such as OPTiM Cloud IoT OS and OPTiM Store, a platform to create business app marketplace; and robotics/hardware services. The company also provides other services comprising Optimal Biz, which allows an IT administrator to manage IT devices in an office; Optimal Remote, a support tool to provide support and reduce diagnostic time, as well as a maintenance tool to control terminals located in distant places; Optimal Second Sight, a solution for live video to be shared through a smart glass, smartphone, or tablet; and OPTiM Café, a service that allows screen sharing without adapter for devices. In addition, it offers support services, which include Optimal Diagnosis and Repair, a tool to find and repair troubles on smartphones, tablets, PCs, and routers on the network; and Optimal Setup to automatically setup routers that are available for telecommunication carriers, as well as Optimal Guard to prevent spoofing and information leakage by detecting, stopping, and deleting malicious executable files. The company was incorporated in 2000 and is headquartered in Tokyo, Japan.

Full OTPMF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this OTPMF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OTPMF vs SCHDOTPMF vs JEPIOTPMF vs OOTPMF vs KOOTPMF vs MAINOTPMF vs JNJOTPMF vs MRKOTPMF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.